Quite right.
Its certainly amazing to see the efficacy of the underlying drug.
Its brilliant to get the above naturally without any serious AE's, full stop.
Then its more amazing to get multiple pathways to target in terms of the said drug's action...signalling...downregulation...encouragement of chondrocytes, regulation of nutrients and just enough vascular enhancement to make a big difference etc etc.
But now add the voices that are building:
Top PI's
(eg Dr T Schnitzer, Dr R. Giugliani)
Top OA researchers and advocates: Dr D Felson, Dr V Kraus and now Dr S Lohmander.
The people in the know...are following us.
It may not be too long before the next stage begins - meaningful material investors and partnering options to come.
Only my views.
Ann: Paradigm AGM Presentation, page-110
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |